Ind-Swift Ltd launches its finished dosage products in Qatar

Expanding its reach in the markets of GCC Countries, Ind-Swift Limited (ISL) launched its finished dosages products in the markets of Qatar.

At a recently held event, Indian Ambassador to Qatar Dr Deepak Mittal launched a range of cardio diabetic & antibiotic products of ISL in Qatar. The launch event was held in partnership with WellcareGroup. Wellcare Group is the authorized distributor of Ind-Swift’s products in Qatar & is one of the leading healthcare distribution companies in Qatar and represents more than 100 brands with a distribution lineup of customers from leading government and semigovernment establishments, private hospital and medical centres, pharmacies and other institutions.

The event was graced by IBPC President Jaffer Siddique, Normal Wong-Lead Instructor, University of Doha for Science & Technology, Dr Ashraf Karara-HOD at Doha Clinic Hospitals & Dr Anoj George-Vice President Indian Doctor's Club. Mr Sridhar, DGM-Middle East Region highlighted,during the event, the strict quality control & procedures followed at Ind Swift's MHRA approved facility from where the products to Qatar market shall be supplied. Mr. Sahil Munjal - Director operations expressed that the Company’s focus to expand its products reach in the market of GCC Countries.

Current Status &Future plan in GCC CountriesIn UAE, currently, Ind-Swift has a total of 6 products (including line extensions) which are marketed by a dedicated team of 4 MRs and a National Sales Manager. Ind-Swift has major expansion plans to increase the product line to 23 products for UAE market.

With 27 products (including line extensions) under registration in Oman with our partner AlHasar Pharmacy, Oman is an important market amongst the GCC.

With current 8 products and tie up with its distributor-Wellcare group, Qatar is emerging as a potential focus market for Ind-Swift.

Apart from these countries, Ind-Swift is also supplying its products in market of Iraq & Yemen and making available quality products at an affordable price to customers.

Shares of IND-SWIFT Limited was last trading in BSE at Rs. 9.20 as compared to the previous close of Rs. 9.30. The total number of shares traded during the day was 5267 in over 24 trades.

The stock hit an intraday high of Rs. 9.60 and intraday low of 8.84. The net turnover during the day was Rs. 48383.00.

Source : Equity Bulls

Keywords

INDSWIFT Pharmaceuticals INE788B01028 FinishedDosageProducts Qatar